국소 의약품 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Topical Pharmaceuticals Market - Scope of Report

TMR's report on the global topical pharmaceuticals market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global topical pharmaceuticals market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global topical pharmaceuticals market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the topical pharmaceuticals market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global topical pharmaceuticals market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global topical pharmaceuticals market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global topical pharmaceuticals market.

The report delves into the competitive landscape of the global topical pharmaceuticals market. Key players operating in the global topical pharmaceuticals market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global topical pharmaceuticals market profiled in this report.

Key Questions Answered in Global topical pharmaceuticals Market Report:

• What is the sales/revenue generated by topical pharmaceuticals across all regions during the forecast period?
• What are the opportunities in the global topical pharmaceuticals market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Topical Pharmaceuticals Market - Research Objectives and Research Approach

The comprehensive report on the global topical pharmaceuticals market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global topical pharmaceuticals market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global topical pharmaceuticals market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Topical Pharmaceuticals Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Topical Pharmaceuticals Market Analysis and Forecast, 2020 to 2035
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. Key Industry Events
• 5.2. PESTEL Analysis
• 5.3. PORTER's Five Forces Analysis
• 5.4. Reimbursement Scenario by Key Countries/Regions
• 5.5. Pipeline Analysis
• 5.6. Unmet Needs of the Market
• 5.7. Government Initiatives

6. Global Topical Pharmaceuticals Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product Type, 2020 to 2035
  • 6.3.1. Semi-Solid Formulations
    • 6.3.1.1. Creams
    • 6.3.1.2. Ointments & Pastes
    • 6.3.1.3. Lotions
    • 6.3.1.4. Gel
  • 6.3.2. Liquid Formulations
    • 6.3.2.1. Suspensions
    • 6.3.2.2. Solutions
  • 6.3.3. Others
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Topical Pharmaceuticals Market Analysis and Forecast, by Application

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by Application, 2020 to 2035
  • 7.3.1. Dermatological Treatments
  • 7.3.2. Wound Healing
  • 7.3.3. Anti-inflammatory Studies
  • 7.3.4. Others
• 7.4. Market Attractiveness Analysis, by Application

8. Global Topical Pharmaceuticals Market Analysis and Forecast, by Distribution Channel

• 8.1. Introduction & Definition
• 8.2. Key Findings/Developments
• 8.3. Market Value Forecast, by Distribution Channel, 2020 to 2035
  • 8.3.1. Hospital Pharmacies
  • 8.3.2. Retail Pharmacies
  • 8.3.3. Online Pharmacies
• 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Topical Pharmaceuticals Market Analysis and Forecast, by Region

• 9.1. Key Findings
• 9.2. Market Value Forecast, by Region, 2020 to 2035
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness Analysis, by Region

10. North America Topical Pharmaceuticals Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 10.2.1. Semi-Solid Formulations
    • 10.2.1.1. Creams
    • 10.2.1.2. Ointments & Pastes
    • 10.2.1.3. Lotions
    • 10.2.1.4. Gel
  • 10.2.2. Liquid Formulations
    • 10.2.2.1. Suspensions
    • 10.2.2.2. Solutions
  • 10.2.3. Others
• 10.3. Market Value Forecast, by Application, 2020 to 2035
  • 10.3.1. Dermatological Treatments
  • 10.3.2. Wound Healing
  • 10.3.3. Anti-inflammatory Studies
  • 10.3.4. Others
• 10.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
  • 10.4.1. Hospital Pharmacies
  • 10.4.2. Retail Pharmacies
  • 10.4.3. Online Pharmacies
• 10.5. Market Value Forecast, by Country, 2020 to 2035
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product Type
  • 10.6.2. By Application
  • 10.6.3. By Distribution Channel
  • 10.6.4. By Country

11. Europe Topical Pharmaceuticals Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 11.2.1. Semi-Solid Formulations
    • 11.2.1.1. Creams
    • 11.2.1.2. Ointments & Pastes
    • 11.2.1.3. Lotions
    • 11.2.1.4. Gel
  • 11.2.2. Liquid Formulations
    • 11.2.2.1. Suspensions
    • 11.2.2.2. Solutions
  • 11.2.3. Others
• 11.3. Market Value Forecast, by Application, 2020 to 2035
  • 11.3.1. Dermatological Treatments
  • 11.3.2. Wound Healing
  • 11.3.3. Anti-inflammatory Studies
  • 11.3.4. Others
• 11.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
  • 11.4.1. Hospital Pharmacies
  • 11.4.2. Retail Pharmacies
  • 11.4.3. Online Pharmacies
• 11.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 11.5.1. Germany
  • 11.5.2. UK
  • 11.5.3. France
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product Type
  • 11.6.2. By Application
  • 11.6.3. By Distribution Channel
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Topical Pharmaceuticals Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 12.2.1. Semi-Solid Formulations
    • 12.2.1.1. Creams
    • 12.2.1.2. Ointments & Pastes
    • 12.2.1.3. Lotions
    • 12.2.1.4. Gel
  • 12.2.2. Liquid Formulations
    • 12.2.2.1. Suspensions
    • 12.2.2.2. Solutions
  • 12.2.3. Others
• 12.3. Market Value Forecast, by Application, 2020 to 2035
  • 12.3.1. Dermatological Treatments
  • 12.3.2. Wound Healing
  • 12.3.3. Anti-inflammatory Studies
  • 12.3.4. Others
• 12.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
  • 12.4.1. Hospital Pharmacies
  • 12.4.2. Retail Pharmacies
  • 12.4.3. Online Pharmacies
• 12.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product Type
  • 12.6.2. By Application
  • 12.6.3. By Distribution Channel
  • 12.6.4. By Country/Sub-region

13. Latin America Topical Pharmaceuticals Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 13.2.1. Semi-Solid Formulations
    • 13.2.1.1. Creams
    • 13.2.1.2. Ointments & Pastes
    • 13.2.1.3. Lotions
    • 13.2.1.4. Gel
  • 13.2.2. Liquid Formulations
    • 13.2.2.1. Suspensions
    • 13.2.2.2. Solutions
  • 13.2.3. Others
• 13.3. Market Value Forecast, by Application, 2020 to 2035
  • 13.3.1. Dermatological Treatments
  • 13.3.2. Wound Healing
  • 13.3.3. Anti-inflammatory Studies
  • 13.3.4. Others
• 13.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
  • 13.4.1. Hospital Pharmacies
  • 13.4.2. Retail Pharmacies
  • 13.4.3. Online Pharmacies
• 13.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product Type
  • 13.6.2. By Application
  • 13.6.3. By Distribution Channel
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Topical Pharmaceuticals Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast, by Product Type, 2020 to 2035
  • 14.2.1. Semi-Solid Formulations
    • 14.2.1.1. Creams
    • 14.2.1.2. Ointments & Pastes
    • 14.2.1.3. Lotions
    • 14.2.1.4. Gel
  • 14.2.2. Liquid Formulations
    • 14.2.2.1. Suspensions
    • 14.2.2.2. Solutions
  • 14.2.3. Others
• 14.3. Market Value Forecast, by Application, 2020 to 2035
  • 14.3.1. Dermatological Treatments
  • 14.3.2. Wound Healing
  • 14.3.3. Anti-inflammatory Studies
  • 14.3.4. Others
• 14.4. Market Value Forecast, by Distribution Channel, 2020 to 2035
  • 14.4.1. Hospital Pharmacies
  • 14.4.2. Retail Pharmacies
  • 14.4.3. Online Pharmacies
• 14.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Product Type
  • 14.6.2. By Application
  • 14.6.3. By Distribution Channel
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Market Share Analysis, by Company (2024)
• 15.3. Company Profiles
  • 15.3.1. Bayer AG
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. Cipla
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. Recent Developments
  • 15.3.3. GSK plc
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. Johnson & Johnson Services, Inc.
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. Novartis AG
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. Bausch Health Companies Inc.
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. Hisamitsu Pharmaceuticals Co., Inc.
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. Merck KGaA
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments
  • 15.3.9. Glenmark Pharmaceuticals LTD.
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Financial Overview
    • 15.3.9.3. Product Portfolio
    • 15.3.9.4. Business Strategies
    • 15.3.9.5. Recent Developments
  • 15.3.10. MedPharm Ltd.
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Financial Overview
    • 15.3.10.3. Product Portfolio
    • 15.3.10.4. Business Strategies
    • 15.3.10.5. Recent Developments
  • 15.3.11. Galderma
    • 15.3.11.1. Company Overview
    • 15.3.11.2. Financial Overview
    • 15.3.11.3. Product Portfolio
    • 15.3.11.4. Business Strategies
    • 15.3.11.5. Recent Developments
  • 15.3.12. Teva Pharmaceuticals
    • 15.3.12.1. Company Overview
    • 15.3.12.2. Financial Overview
    • 15.3.12.3. Product Portfolio
    • 15.3.12.4. Business Strategies
    • 15.3.12.5. Recent Developments
  • 15.3.13. Boehringer Ingelheim International GmBH
    • 15.3.13.1. Company Overview
    • 15.3.13.2. Financial Overview
    • 15.3.13.3. Product Portfolio
    • 15.3.13.4. Business Strategies
    • 15.3.13.5. Recent Developments
  • 15.3.14. Pfizer Inc.
    • 15.3.14.1. Company Overview
    • 15.3.14.2. Financial Overview
    • 15.3.14.3. Product Portfolio
    • 15.3.14.4. Business Strategies
    • 15.3.14.5. Recent Developments